|Bid||3.18 x 0|
|Ask||2.90 x 0|
|Day's range||3.02 - 3.07|
|52-week range||2.26 - 3.86|
|Beta (3Y monthly)||1.71|
|PE ratio (TTM)||160.53|
|Earnings date||23 Aug. 2016 - 27 Aug. 2016|
|Forward dividend & yield||N/A (N/A)|
|1y target est||3.32|
Nanosonics Ltd (ASX:NAN) shares are one of three in the healthcare sector that I think could be great long-term buy and hold investments...
News of the recent correction in global share markets can make for gloomy reading – but it also provides a great opportunity to pick up quality shares at bargain prices. Mayne Pharma Group Ltd (ASX:MYX) might be one such growth company worth stocking up on.
Volpara Health Technologies Ltd (ASX:VHT) shares are one of three small caps in the healthcare sector that I would buy this month...
Building up an investment case requires looking at a stock holistically. Today I’ve chosen to put the spotlight on Nanosonics Limited (ASX:NAN) due to its excellent fundamentals in more thanRead More...
Nanosonics Ltd (ASX:NAN) shares are one of three at the small end of the healthcare sector that you'll find on my watchlist...
Magellan Financial Group Ltd (ASX:MFG) and Macquarie Group Ltd (ASX:MQG) could offer reasonable total returns over the next 18 months.
Over the last 5 years, CSL Limited (ASX:CSL) has delivered gains of well over 200% to its long term shareholders, demonstrating the explosive growth potential of companies in the biotech industry. Here are three under-the-radar medical companies that could be in the running to be the next CSL.